ESMO GI 2024 Insights: DEEPER Trial - m-FOLFOXIRI + Cetuximab vs. Bevacizumab in Right-Sided/BRAF Mutant mCRC

0 views
July 11, 2024
Comments 0
Login to view comments. Click here to Login